25th May, 2021
Developing a Successful Global Vaccination Programme: Ensuring Poorer Nations Have Equal Access to Vaccines, Funds and Infrastructure for Successful Rollout – Click here for more information
Vaccination is the single biggest priority for most nations around the world that have been affected by the Covid-19 pandemic. Although the UK, USA, Israel, the European Union and other western countries are well underway with mass immunisation, Least Developed Countries (LDCs) have been unable to secure enough doses to do the same. Pre-orders from developed nations, lack of funding, obstacles with logistics and supply chain, bureaucracy, challenges with existing healthcare infrastructure are just some challenges faced by poorer nations in their mass immunisation journey. In fact, recent research suggests that widespread vaccination coverage will not take place till 2023 for these countries while the rest of the world is poised to complete this by 2022.
One of the key consequences of the coronavirus is increased debt faced by LDCs due to declines in GDP, Foreign Direct Investment and foreign remittances. Declines in major commodities like oil, minerals and food exports have further contracted the economies of these countries.
To address this urgent and serious crisis, the World Health Organisation, along with CEPI and GAVI are spearheading the Covid-19 Vaccines Global Access initiative or Covax. It aims to deliver doses for at least 20% of countries’ populations, actively manage the portfolio of vaccines, deliver them as soon as possible, end the acute phase of the pandemic and help rebuild the economies of countries adversely affected by it.
This symposium will bring together policy makers, healthcare professionals, international organisations and other key stakeholders from around the world to discuss current challenges and opportunities in the rollout of the Covax initiative in LDCs
To register for the briefing, please click here.